申请人:BIOCRYST PHARMACEUTICALS, INC.
公开号:US20170266172A1
公开(公告)日:2017-09-21
Use of a compound of formula (I): wherein A, X, Y, R
1
and R
2
as defined herein, in treating hereditary angioedema is disclosed. A composition containing the compounds, a polar organic solvent or a mixture thereof; and optionally a co-solvent, is also disclosed.